Global and China NGS-based RNA-seq Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.

    Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.

    This report elaborates on the current development of the NGS-based RNA-seq industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Perkinelmer

    • Gatc Biotech

    • Qaigen

    • Illumina

    • Thermo Fisher Scientific

    • Macrogen

    • Agilent Technologies

    • Eurofins Scientific

    • F Hoffmann-La Roche

    • Pacific Biosciences Of California

    • Oxford Nanopore Technologies

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • SBS

    • SMRT

    Application:

    • Transcriptome Epigenetics

    • Small RNA

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 NGS-based RNA-seq Industry Overview

      • 1.1.1 NGS-based RNA-seq Market Scope and Market Segments

      • 1.1.2 NGS-based RNA-seq Industry Characteristics

      • 1.1.3 Global and China NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China NGS-based RNA-seq Production Value and Growth Rate (2017-2028)

    • 1.2 Global NGS-based RNA-seq Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 SBS

      • 1.2.2 SMRT

    • 1.3 Global NGS-based RNA-seq Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Transcriptome Epigenetics

      • 1.3.2 Small RNA

    • 1.4 Market Analysis by Region

      • 1.4.1 North America NGS-based RNA-seq Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe NGS-based RNA-seq Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC NGS-based RNA-seq Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa NGS-based RNA-seq Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global NGS-based RNA-seq Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global NGS-based RNA-seq Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China NGS-based RNA-seq Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China NGS-based RNA-seq Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global NGS-based RNA-seq Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 NGS-based RNA-seq Industry Porter's Five Forces Model Analysis

      • 2.2.3 NGS-based RNA-seq Industry PEST Analysis

    • 2.3 NGS-based RNA-seq Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 NGS-based RNA-seq Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on NGS-based RNA-seq Industry

    Chapter 3 Global and China NGS-based RNA-seq Market, by Manufacturer

    • 3.1 Global and China NGS-based RNA-seq Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China NGS-based RNA-seq Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China NGS-based RNA-seq Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China NGS-based RNA-seq Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China NGS-based RNA-seq Market Top 3 Players

    Chapter 4 Global and China NGS-based RNA-seq Market, by Type (2017-2028)

    • 4.1 NGS-based RNA-seq Market Trend, by Type

    • 4.2 Global NGS-based RNA-seq Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global NGS-based RNA-seq Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global NGS-based RNA-seq Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global NGS-based RNA-seq Price Trend, by Type (2017-2028)

    • 4.3 China NGS-based RNA-seq Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China NGS-based RNA-seq Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China NGS-based RNA-seq Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China NGS-based RNA-seq Price Trend, by Type (2017-2028)

    Chapter 5 Global and China NGS-based RNA-seq Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global NGS-based RNA-seq Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global NGS-based RNA-seq Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global NGS-based RNA-seq Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China NGS-based RNA-seq Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China NGS-based RNA-seq Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China NGS-based RNA-seq Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global NGS-based RNA-seq Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America NGS-based RNA-seq Market Analysis

    • 7.1 North America NGS-based RNA-seq Market, by Type

    • 7.2 North America NGS-based RNA-seq Market, by Application

    • 7.3 North America NGS-based RNA-seq Market Analysis and Forecast, by Country

      • 7.3.1 United States NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe NGS-based RNA-seq Market Analysis

    • 8.1 Europe NGS-based RNA-seq Market, by Type

    • 8.2 Europe NGS-based RNA-seq Market, by Application

    • 8.3 Europe NGS-based RNA-seq Market Analysis and Forecast, by Country

      • 8.3.1 Germany NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC NGS-based RNA-seq Market Analysis

    • 9.1 APAC NGS-based RNA-seq Market, by Type

    • 9.2 APAC NGS-based RNA-seq Market, by Application

    • 9.3 APAC NGS-based RNA-seq Market Analysis and Forecast, by Country

      • 9.3.1 China NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa NGS-based RNA-seq Market Analysis

    • 10.1 Latin America, Middle East and Africa NGS-based RNA-seq Market, by Type

    • 10.2 Latin America, Middle East and Africa NGS-based RNA-seq Market, by Application

    • 10.3 Latin America, Middle East and Africa NGS-based RNA-seq Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China NGS-based RNA-seq Company Profiles

      • 11.1 Perkinelmer

        • 11.1.1 Perkinelmer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Perkinelmer NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.1.3 Perkinelmer NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Gatc Biotech

        • 11.2.1 Gatc Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Gatc Biotech NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.2.3 Gatc Biotech NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Qaigen

        • 11.3.1 Qaigen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Qaigen NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.3.3 Qaigen NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Illumina

        • 11.4.1 Illumina Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Illumina NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.4.3 Illumina NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Thermo Fisher Scientific

        • 11.5.1 Thermo Fisher Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Thermo Fisher Scientific NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.5.3 Thermo Fisher Scientific NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Macrogen

        • 11.6.1 Macrogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Macrogen NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.6.3 Macrogen NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Agilent Technologies

        • 11.7.1 Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Agilent Technologies NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.7.3 Agilent Technologies NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Eurofins Scientific

        • 11.8.1 Eurofins Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Eurofins Scientific NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.8.3 Eurofins Scientific NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 F Hoffmann-La Roche

        • 11.9.1 F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 F Hoffmann-La Roche NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.9.3 F Hoffmann-La Roche NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Pacific Biosciences Of California

        • 11.10.1 Pacific Biosciences Of California Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Pacific Biosciences Of California NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.10.3 Pacific Biosciences Of California NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Oxford Nanopore Technologies

        • 11.11.1 Oxford Nanopore Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Oxford Nanopore Technologies NGS-based RNA-seq Product Profiles, Application and Specification

        • 11.11.3 Oxford Nanopore Technologies NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 NGS-based RNA-seq Industry Investment Prospect and Risk Assessment

    • 12.1 NGS-based RNA-seq Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 NGS-based RNA-seq Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure China NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Global NGS-based RNA-seq Production Value and Growth Rate (2017-2028)

    • Figure China NGS-based RNA-seq Production Value and Growth Rate (2017-2028)

    • Figure Global NGS-based RNA-seq Market Size and Growth Rate of SBS (2017-2028)

    • Figure Global NGS-based RNA-seq Market Size and Growth Rate of SMRT (2017-2028)

    • Figure Global NGS-based RNA-seq Market Size and Growth Rate of Transcriptome Epigenetics (2017-2028)

    • Figure Global NGS-based RNA-seq Market Size and Growth Rate of Small RNA (2017-2028)

    • Figure North America NGS-based RNA-seq Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe NGS-based RNA-seq Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC NGS-based RNA-seq Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa NGS-based RNA-seq Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global NGS-based RNA-seq Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China NGS-based RNA-seq Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China NGS-based RNA-seq Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China NGS-based RNA-seq Sales Value, by Manufacturer (2021&2022)

    • Table Global and China NGS-based RNA-seq Market Share, by Manufacturer (2021&2022)

    • Figure Global and China NGS-based RNA-seq Market Share, by Manufacturer in 2021

    • Figure Global and China NGS-based RNA-seq Market Share, by Manufacturer in 2022

    • Table Global NGS-based RNA-seq Sales Volume, by Type (2017-2028)

    • Table Global NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Figure Global NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Table Global NGS-based RNA-seq Sales Value, by Type (2017-2028)

    • Table Global NGS-based RNA-seq Sales Value Share, by Type (2017-2028)

    • Figure Global NGS-based RNA-seq Price Trend, by Type (2017-2028)

    • Table China NGS-based RNA-seq Sales Volume, by Type (2017-2028)

    • Table China NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Figure China NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Table China NGS-based RNA-seq Sales Value, by Type (2017-2028)

    • Table China NGS-based RNA-seq Sales Value Share, by Type (2017-2028)

    • Figure China NGS-based RNA-seq Price Trend, by Type (2017-2028)

    • Table Global NGS-based RNA-seq Sales Volume, by Application (2017-2028)

    • Table Global NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure Global NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Table Global NGS-based RNA-seq Sales Value, by Application (2017-2028)

    • Table Global NGS-based RNA-seq Sales Value Share, by Application (2017-2028)

    • Figure Global NGS-based RNA-seq Sales Value Share, by Application (2017-2028)

    • Table China NGS-based RNA-seq Sales Volume, by Application (2017-2028)

    • Table China NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure China NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Table China NGS-based RNA-seq Sales Value, by Application (2017-2028)

    • Table China NGS-based RNA-seq Sales Value Share, by Application (2017-2028)

    • Figure China NGS-based RNA-seq Sales Value Share, by Application (2017-2028)

    • Figure China NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    • Figure North America NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    • Figure Europe NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    • Figure APAC NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa NGS-based RNA-seq Production, Import, Consumption and Export (2017-2022)

    • Table North America NGS-based RNA-seq Sales Volume, by Type (2017-2028)

    • Table North America NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Figure North America NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Table North America NGS-based RNA-seq Sales Volume, by Application (2017-2028)

    • Table North America NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure North America NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure United States NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure United States NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Canada NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Canada NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Mexico NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Table Europe NGS-based RNA-seq Sales Volume, by Type (2017-2028)

    • Table Europe NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Figure Europe NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Table Europe NGS-based RNA-seq Sales Volume, by Application (2017-2028)

    • Table Europe NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure Europe NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure Germany NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Germany NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure UK NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure UK NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure France NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure France NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Italy NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Italy NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Spain NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Spain NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Belgium NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Poland NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Poland NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Russia NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Russia NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Turkey NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Table APAC NGS-based RNA-seq Sales Volume, by Type (2017-2028)

    • Table APAC NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Figure APAC NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Table APAC NGS-based RNA-seq Sales Volume, by Application (2017-2028)

    • Table APAC NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure APAC NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure China NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure China NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Japan NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Japan NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure India NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure India NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure South Korea NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa NGS-based RNA-seq Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa NGS-based RNA-seq Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa NGS-based RNA-seq Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa NGS-based RNA-seq Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Brazil NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure South Africa NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Figure Argentina NGS-based RNA-seq Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina NGS-based RNA-seq Sales Value and Growth Rate (2017-2028)

    • Table Perkinelmer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Perkinelmer Product Profiles, Application and Specification

    • Table Perkinelmer NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gatc Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gatc Biotech Product Profiles, Application and Specification

    • Table Gatc Biotech NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Qaigen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Qaigen Product Profiles, Application and Specification

    • Table Qaigen NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Illumina Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Illumina Product Profiles, Application and Specification

    • Table Illumina NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Thermo Fisher Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Thermo Fisher Scientific Product Profiles, Application and Specification

    • Table Thermo Fisher Scientific NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Macrogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Macrogen Product Profiles, Application and Specification

    • Table Macrogen NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agilent Technologies Product Profiles, Application and Specification

    • Table Agilent Technologies NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eurofins Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eurofins Scientific Product Profiles, Application and Specification

    • Table Eurofins Scientific NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pacific Biosciences Of California Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pacific Biosciences Of California Product Profiles, Application and Specification

    • Table Pacific Biosciences Of California NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Oxford Nanopore Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Oxford Nanopore Technologies Product Profiles, Application and Specification

    • Table Oxford Nanopore Technologies NGS-based RNA-seq Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.